Advances in rapid diagnostics for bloodstream infections

Area of Science:

• Medical Diagnostics
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Bloodstream infections (BSI) cause significant inpatient mortality and high healthcare costs in the US.
• Rapid advancements in diagnostic technologies aim to accelerate pathogen identification and antimicrobial susceptibility testing (AST).
• Clinical impact of new diagnostics is variable, influenced by the need for conventional AST and understanding of evolving platforms.

Purpose of the Study:

• To review key advancements in rapid diagnostics for BSI.
• To highlight the crucial role of antimicrobial stewardship in optimizing the use of these new technologies.

Main Methods:

• Review of recent developments in rapid identification methods (e.g., MALDI-TOF MS, multiplex PCR).
• Examination of emerging rapid phenotypic AST technologies.
• Analysis of the integration of rapid diagnostics with antimicrobial stewardship programs.

Main Results:

• While rapid genotypic resistance detection is expanding, rapid phenotypic AST is a more recent development.
• Improved patient outcomes are most consistently observed when rapid diagnostic platforms are used alongside active antimicrobial stewardship.
• The synergy between advanced diagnostics and stewardship is essential for effective BSI management.

Conclusions:

• Rapid diagnostic platforms offer significant potential for improving BSI care.
• Effective antimicrobial stewardship is indispensable for realizing the full clinical benefits of rapid diagnostics.
• Future strategies must integrate technological advancements with robust stewardship practices for optimal patient outcomes.